GE HealthCare Technologies Inc. GEHC
Stock research in plain language · As of Oct 04, 2026 · updated once a week, after the trading week closes
What the company does
GE HealthCare Technologies Inc. is a large-cap company in the Healthcare sector (Medical Devices), with a market value of $29.0B, based in the USA.
It employs about 54,000 people and has been listed since Jan 04, 2023.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
Cheap or expensive? relatively cheap
Its price-to-earnings (P/E) is 14.8 versus 31.6 for the median of the Healthcare sector in our universe (22 companies) — relatively cheap.
Revenue is growing 6% versus the same quarter last year.
On analysts' next-year forecasts the multiple drops to 12.1 — they expect higher earnings.
The average analyst price target is 83.05, 29% above the current price (their view, not ours).
The stock sits at 18% of its one-year range (0% = the low, 100% = the high).
The risks
- • More cash leaves than comes in (negative free cash flow).
Strengths
- ✅ Profitable — 11 of every 100 dollars of revenue stays as profit.
- ✅ Most analysts rate it buy (15 vs 0).
- ✅ Pays a dividend (0.2% a year).
What changed this week
Over the past week the stock fell 3.5% (for comparison: S&P 500 -0.2%, sector ETF XLV -2.6%).
No notable news about the company was found in the past week.
A description of facts from the filings and the market — not investment advice or a recommendation. "Cheap" and "expensive" are always relative to the comparison group.